No Data
No Data
Cabaletta Bio Price Target Lowered to $13 From $26 at Stifel
Cabaletta Bio | 10-K: FY2024 Annual Report
Cabaletta Bio Reports Q4 EPS (65c), Consensus (63c)
Cabaletta Bio | 8-K: Cabaletta Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Press Release: Cabaletta Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Express News | Cabaletta Bio Q4 Income From Operations USD -33.785 Million